DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2270082/pubmatic-inc-pubm-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270082 May 07, 2024 - PubMatic (PUBM) delivered earnings and revenue surprises of 58.33% and 7.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2270073/kinross-gold-kgc-tops-q1-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270073 May 07, 2024 - Kinross Gold (KGC) delivered earnings and revenue surprises of 66.67% and 23.34%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2270081/the-realreal-real-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270081 May 07, 2024 - The RealReal (REAL) delivered earnings and revenue surprises of 14.29% and 3.53%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2270064/gopro-gpro-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270064 May 07, 2024 - GoPro (GPRO) delivered earnings and revenue surprises of 12.50% and 5.61%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2270065/clover-health-investments-corp-clov-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270065 May 07, 2024 - Clover Health Investments (CLOV) delivered earnings and revenue surprises of 28.57% and 9.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2270059/oddity-tech-odd-q1-earnings-and-revenues-top-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270059 May 07, 2024 - Oddity Tech (ODD) delivered earnings and revenue surprises of 24.49% and 2.96%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2270027/alpha-and-omega-semiconductor-aosl-reports-q3-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270027 May 07, 2024 - Alpha and Omega (AOSL) delivered earnings and revenue surprises of 71.43% and 0.04%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2270038/myriad-genetics-mygn-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270038 May 07, 2024 - Myriad (MYGN) delivered earnings and revenue surprises of 90.91% and 4.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2270017/maxcyte-inc-mxct-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270017 May 07, 2024 - MaxCyte (MXCT) delivered earnings and revenue surprises of 35.71% and 46.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2270022/ligand-pharmaceuticals-lgnd-tops-q1-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270022 May 07, 2024 - Ligand (LGND) delivered earnings and revenue surprises of 6.19% and 4.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0